Innovative Medicines Initiative (IMI): pubblicato il nuovo bando

Per qualsiasi ulteriore informazione è possibile visitare la relativa pagina del sito web ufficiale IMI. Fino al 15 dicembre sono stati programmati una serie di webinars dedicati a vari aspetti della futura call.

Di seguito i topics inclusi nella call:

• Topic 1: Assessment of the uniqueness of diabetic cardiomyopathy relative to other forms of heart failure using unbiased pheno-mapping approaches
• Topic 2: Genome-Environment Interactions in Inflammatory Skin Disease
• Topic 3: The value of diagnostics to combat antimicrobial resistance by optimising antibiotic use
• Topic 4: Mitochondrial Dysfunction in Neurodegeneration
• Topic 5: Support and coordination action for the projects in the neurodegeneration area of the Innovative Medicines Initiative
• Topic 6: A sustainable European induced pluripotent stem cell platform
• Topic 7: Linking digital assessment of mobility to clinical endpoints to support regulatory acceptance and clinical practice
• Topic 8: Human tumour microenvironment immunoprofiling
• Topic 9: ConcePTION – Continuum of Evidence from Pregnancy Exposures, Reproductive Toxicology and Breastfeeding to Improve Outcomes Now
• Topic 10: Improving the preclinical prediction of adverse effects of pharmaceuticals on the nervous system
• Topic 11: Translational Safety Biomarker Pipeline (TransBioLine): Enabling development and implementation of novel safety biomarkers in clinical trials and diagnosis of disease
• Topic 12: Pilot programme on a Clinical Compound Bank for Repurposing: Cardiovascular diseases and diabetes
• Topic 13: Pilot programme on a Clinical Compound Bank for Repurposing: Respiratory diseases
• Topic 14: Pilot programme on a Clinical Compound Bank for Repurposing: Neurodegenerative diseases
• Topic 15: Pilot programme on a Clinical Compound Bank for Repurposing: Rare/orphan diseases

Scarica il bando